Valuation: Medpace Holdings, Inc.

Capitalization 14.87B 12.59B 11.59B 10.97B 20.33B 1,376B 20.68B 136B 53.22B 667B 55.77B 54.61B 2,350B P/E ratio 2026 *
30.4x
P/E ratio 2027 * 27.4x
Enterprise value 13.87B 11.75B 10.81B 10.23B 18.96B 1,283B 19.29B 127B 49.63B 622B 52.02B 50.93B 2,192B EV / Sales 2026 *
4.94x
EV / Sales 2027 * 4.45x
Free-Float
83.69%
Yield 2026 *
-
Yield 2027 * -
1 day+0.96%
1 week+5.48%
Current month+8.42%
1 month+14.38%
3 months-14.78%
6 months-1.41%
Current year-7.31%
1 week 492.96
Extreme 492.965
530.97
1 month 446.89
Extreme 446.8882
530.97
Current year 392.35
Extreme 392.35
628.92
1 year 250.05
Extreme 250.05
628.92
3 years 185.43
Extreme 185.43
628.92
5 years 126.94
Extreme 126.945
628.92
10 years 21.76
Extreme 21.76
628.92
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
President 51 01/08/2021
Director TitleAgeSince
Director/Board Member 74 13/08/2018
Chairman 69 01/07/1992
Director/Board Member 66 13/08/2018
Change 5d. change 1-year change 3-years change Capi.($)
+0.96%+5.48%+75.71%+166.26% 14.87B
+2.22%+5.51%+0.78%-7.93% 48.69B
+0.99%+4.59%+40.22%+22.31% 35.92B
-0.43%+54.13%+304.33%+504.92% 31.26B
-0.72%+3.91%+35.55%+29.11% 29.77B
+2.62%+5.45%+22.62%-12.91% 29.62B
-6.22%-0.52%+3,641.35%+3,836.02% 14.18B
+0.63%+2.17%+48.12%+195.41% 15.1B
+0.87%+8.85%+40.89%+13.56% 14.5B
+0.60%+0.72%+166.58%+100.40% 12.51B
Average +0.15%+8.90%+437.62%+484.72% 24.64B
Weighted average by Cap. +0.58%+10.59%+279.51%+316.30%

Financials

2026 *2027 *
Net sales 2.81B 2.38B 2.19B 2.07B 3.84B 260B 3.91B 25.63B 10.05B 126B 10.53B 10.31B 444B 3.02B 2.56B 2.36B 2.23B 4.13B 280B 4.21B 27.61B 10.82B 136B 11.34B 11.11B 478B
Net income 497M 421M 387M 367M 680M 45.99B 691M 4.54B 1.78B 22.29B 1.86B 1.83B 78.58B 552M 468M 430M 407M 755M 51.08B 768M 5.04B 1.98B 24.76B 2.07B 2.03B 87.27B
Net Debt -1B -848M -780M -738M -1.37B -92.59B -1.39B -9.13B -3.58B -44.88B -3.75B -3.68B -158B -1.41B -1.19B -1.1B -1.04B -1.93B -131B -1.96B -12.88B -5.05B -63.27B -5.29B -5.18B -223B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a global provider of clinical research-based drug and medical device development services. The Company is focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. Its drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Its operations are based in North America, Europe, and Asia.
Employees
6,200
Date Price Change Volume
17/04/26 520.60 $ +0.96% 629,940
16/04/26 515.65 $ -0.56% 345,112
15/04/26 518.54 $ -0.28% 547,766
14/04/26 520.00 $ +3.74% 326,279
13/04/26 501.23 $ +1.56% 203,886
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
520.60USD
Average target price
500.08USD
Spread / Average Target
-3.94%

Quarterly revenue - Rate of surprise